ICKSH 2024

[JS01] Joint Session 01

Asian Hematology Session I - EBV-associated lymphoid malignancy

Room 1 (Vista Hall 1)

March 28 (Thu), 09:00-10:15
Ki Seong Eom (College of Medicine, The Catholic University of Korea, Korea)
Dok Hyun Yoon (University of Ulsan College of Medicine, Korea)
Prospective studies for NK/T-cell lymphoma in Asia Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) Chronic active EBV disease: Our challenge to elucidate the pathogenesis Ayako Arai (St. Marianna University School of Medicine, Japan) NK lymphoma genomics Weili Zhao (Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China) Discussion

[ES01] Education Session 01

Histiocytic neoplasm

Room 2 (Vista Hall 2)

March 28 (Thu), 09:00-10:15
Nack-Gyun Chung (College of Medicine, The Catholic University of Korea, Korea)
Hyoung Soo Choi (Seoul National University College of Medicine, Korea)
Histiocytic neoplasm in pediatrics Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) Histiocytic sarcoma Sung Nam Lim (Inje University College of Medicine, Korea) Pathologic characteristics of histiocytic and dendritic cell neoplasms Sun Och Yoon (Yonsei University College of Medicine, Korea)

[SS01] Scientific Session 01

Exploring the utilization of innovative technologies

Room 3 (Grand Hall 1)

March 28 (Thu), 09:00-10:15
Young Kyung Lee (Hallym University College of Medicine, Korea)
Yoon Hwan Chang (Seoul National University College of Medicine, Korea)
Elucidating the 3D chromatin landscape of pediatric B-cell acute lymphoblastic leukemia using Micro-C Kajsa Paulsson (Lund University, Sweden) Integrated RNA and protein profiling of B-cell acute lymphoblastic leukemia at single-cell level Sungyoung Choi (Hanyang University College of Medicine, Korea) Leveraging dysregulated signaling networks for therapeutic benefit in myeloproliferative neoplasm Stephen T. Oh (Washington University School of Medicine, USA)

[SS02] Scientific Session 02

The unmet needs in CML - Overcoming the obstacles of the road to cure

Room 4 (Art Hall)

March 28 (Thu), 09:00-10:15
Chul Won Jung (Sungkyunkwan University School of Medicine, Korea)
Hawk Kim (Gachon University College of Medicine, Korea)
Molecular mechanism of primary TKI resistance in CML Jerald Radich (Fred Hutchinson Cancer Center, USA) Targeting leukemic stem cells in CML Mhairi Copland (University of Glasgow, UK) The role of NGS to detect TKI resistance Saeam Shin (Yonsei University College of Medicine, Korea)

[PL01] Plenary Lecture 01

Somatic mutations and clonal dynamics in human blood cells

Room 1+2 (Vista Hall 1+2)

March 28 (Thu), 10:30-11:15
Seoklae Chae (Dongguk University College of Medicine, Korea)
Somatic mutations and clonal dynamics in human blood cells Peter J. Campbell (Wellcome Sanger Institute, UK)

[PS01] Presidential Symposium

Lab-on-a-chip in hematology

Room 1+2 (Vista Hall 1+2)

March 28 (Thu), 11:15-12:00
Seongsoo Jang (University of Ulsan College of Medicine, Korea)
Lab-on-a-chip in hematology Chong H. Ahn (University of Cincinnati, USA)

[SY01] Satellite Symposium 01

Janssen

Room 1 (Vista Hall 1)

March 28 (Thu), 12:15-13:05
Kihyun Kim (Sungkyunkwan University School of Medicine, Korea)
Treatment of newly diagnosed multiple myeloma: Focus on daratumumab combination Elena Zamagni (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Italy)

[SY02] Satellite Symposium 02

Astrazeneca

Room 2 (Vista Hall 2)

March 28 (Thu), 12:15-13:05
Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
The ultimate value of C5 inhibitors in the evolving treatment landscape of PNH Sung-Hyun Kim (Dong-A University College of Medicine, Korea)

[SY03] Satellite Symposium 03

Astellas

Room 3 (Grand Hall 1)

March 28 (Thu), 12:15-13:05
Hee-Je Kim (College of Medicine, The Catholic University of Korea, Korea)
Treatment strategies for elderly AML with FLT3-mutation, entering the era of FLT3 Inhibitors Naoko Hosono (University of Fukui, Japan)

[SY04] Satellite Symposium 04

Roche

Room 4 (Art Hall)

March 28 (Thu), 12:15-13:05
Sung-Soo Yoon (Seoul National University College of Medicine, Korea)
Advances in the treatment paradigm with bispecific antibodies Wendy Osborne (Newcastle University, UK)

[OP01] Oral Presentation 01

Acute leukemia - 1

Room 1 (Vista Hall 1)

March 28 (Thu), 13:20-14:50
Dae-Young Kim (Ewha Womans University College of Medicine, Korea)
Saeam Shin (Yonsei University College of Medicine, Korea)
The transcriptomic profiles of NPM1 mutated acute myeloid leukemia reveal distinct subtypes characterized by varying clinical outcomes Joon Ho Moon (Kyungpook National University Hospital, Korea) Leukemic stem cells in acute myeloid leukemia further refine treatment outcomes in ELN molecular risk groups Ritu Gupta (All India Institute of Medical Sciences, India) Azacitidine combined with novel flavonoid derivative GL-V9 demonstrated synergistic anti-leukemia effect in acute myeloid leukemia by targeting DDIT4/mTOR signaling Jun Li (Institute of Hematology Southeast University, China) Exploring the genetic landscape of B-ALL: Upregulation of cell adhesion pathway in the high risk adult as com - pared to pediatric B-ALL patients Preity Sharma (All India Institute of Medical Sciences, India) CD371 expression in B-lymphoblastic leukemia and its correlation with recurrent genetic abnormalities Sweta Rajpal (ACTREC, Tata Memorial Centre, India)

[OP02] Oral Presentation 02

Lymphoma

Room 2 (Vista Hall 2)

March 28 (Thu), 13:20-14:50
Ho Sup Lee (Kosin University College of Medicine, Korea)
Youngwoo Jeon (College of Medicine, The Catholic University of Korea, Korea)
Treatment patterns in patients with mantle cell lymphoma: Updated report of the Asia-Pacific multinational retrospective registry study Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) Pooled safety analysis of zanubrutinib monotherapy in Asian patients with B-cell malignancies Won Seog Kim (Sungkyunkwan University School of Medicine, Korea) Prognostic value of end-of-treatment [18F]FDG PET/CT in newly diagnosed patients with primary central ner - vous system lymphoma who respond to first-line treatment with high-dose methotrexate-based regimen Hyungwoo Cho (University of Ulsan College of Medicine, Korea) Efficacy of dexamethasone, L-asparaginase, ifosfamide, carboplatin, and etoposide in patients with relapsed/ refractory peripheral T cell lymphoma Tong Yoon Kim (College of Medicine, The Catholic University of Korea, Korea) Characteristics and outcome of post-transplant lymphoproliferative disease in children treated with low-dose chemotherapy over 20 years in a single hospital Hyery Kim (University of Ulsan College of Medicine, Korea)

[OP03] Oral Presentation 03

Hematopoietic stem cell transplantation & Cellular therapy

Room 3 (Grand Hall 1)

March 28 (Thu), 13:20-14:50
Sung-Hyun Kim (Dong-A University College of Medicine, Korea)
Jieun Uhm (Hanyang University College of Medicine, Korea)
Reduced GVHD incidence with post-transplantation cyclophosphamide in higher-risk myelodysplastic syn - drome Jin-Hee Han (University of Ulsan College of Medicine, Korea) Effect of HLA mismatched on the prognosis of cord blood transplantation for childhood leukemia Lu Liu (Children’s Hospital of Soochow University, China) Interleukin 6 polymorphisms 174 and 597: Impact on graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in childhood Bernd Gruhn (Jena University Hospital, Germany) Reduced 8-Gray versus standard 13.2-gray total dose of total body irradiation based myeloablative conditioning for allogeneic hematopoietic cell transplantation in pediatric acute lymphoblastic leukemia Jae Won Yoo (College of Medicine, The Catholic University of Korea, Korea) High plasmacytoid dendritic cell dose infusion correlates with better plasmacytoid dendritic cell reconstitution and lower incidence of viral infection after transplantation: A single-center study Di Yao (Children’s Hospital of Soochow University, China) BCMA-specific induced pluripotent stem cells and their specific regulatory pathways to differentiate into rejuve - nated antigen-specific memory CD8+ T cells Jooeun Bae (Dana Farber Cancer Institute, USA)

[OP04] Oral Presentation 04

Laboratory hematology

Room 4 (Art Hall)

March 28 (Thu), 13:20-14:50
Sun-Young Kong (National Cancer Center, Korea)
Hyun-Young kim (Sungkyunkwan University School of Medicine, Korea)
Dynamic thrombocytopenia has a negative impact with distinctive genetic and immunologic features in pa - tients with myelofibrosis Tong Yoon Kim (College of Medicine, The Catholic University of Korea, Korea) Ribosomal protein S4X functions as a novel suppressor for SCF complex-mediated ubiquitination of myeloid cell leukemia1 and beta-catenin Satsuki Ryu (Tokushima Bunri University, Japan) Targeted-NGS across the beta-globin gene cluster identifies multiple linkage disequilibrium patterns in north Indian non-transfusion dependent beta-thalassemia patients Prashant Sharma (Research Block A, Postgraduate Institute of Medical Education and Research, India) Novel insight into the role of HTLV-1 unspiced form of bZIP factor: Specific interaction with HS-1 associated protein X-1, preventing caspase9-dependent apoptotic pathway Yuka Tanaka (Tokushima Bunri University, Japan) Immune function of chimeric antigen receptor T cells quantitatively assessed via molecular imaging flow cytom - etry Hiroshi Yasui (The Institute of Medical Science, The University of Tokyo, Japan)

[JS02] Joint Sesseion 02

EHA-KSH Joint Symposium - Multiple myeloma

Room 1 (Vista Hall 1)

March 28 (Thu), 15:05-16:20
Jin Seok Kim (Yonsei University College of Medicine, Korea)
Meral Beksac (Ankara Liv Hospital, Türkiye)
Dynamic assessment of risk in multiple myeloma Meral Beksac (Ankara Liv Hospital, Türkiye) PET/CT for risk stratification in multiple myeloma Joon Ho Moon (Kyungpook National University Hospital, Korea) Bone marrow inflammation in multiple myeloma Tom Cupedo (Erasmus MC Cancer Center, The Netherlands) Single-cell analysis in multiple myeloma Sung-Soo Park (College of Medicine, The Catholic University of Korea, Korea)

[SS03] Scientific Session 03

Wise perspective on new approaches in hemophilia

Room 2 (Vista Hall 2)

March 28 (Thu), 15:05-16:20
Eun Jin Choi (Daegu Catholic University School of Medicine, Korea)
Young Shil Park (Kyung Hee University College of Medicine, Korea)
Approaches to treat people with hemophilia: What’s new and what’s not? Leonard A. Valentino (Rush University, USA) Prospects and challenges of gene therapy for hemophilia Alok Srivastava (Christian Medical College, India) Exploring personalized tailored hemophilia treatment: Tailoring treatment to individual needs Jeong A Park (Inha University College of Medicine, Korea)

[SS04] Scientific Session 04

For the next generation CAR-T cells

Room 3 (Grand Hall 1)

March 28 (Thu), 15:05-16:20
Seok-Goo Cho (College of Medicine, The Catholic University of Korea, Korea)
Je-Jung Lee (Chonnam National University Medical School, Korea)
CD7 CAR-T therapy for treating hematological maligancies Peihua Lu (Lu Daopei Hospital, China) Development of a novel anti-CD19 CAR-T cells in B cell lymphoma Dok Hyun Yoon (University of Ulsan College of Medicine, Korea) CAR-T cells for treatment of T cell malignancies Paul M. Maciocia (Cancer Research UK, UK)

[SS05] Scientific Session 05

Deepened understanding of AML using multi-omics approaches

Room 4 (Art Hall)

March 28 (Thu), 15:05-16:20
Hyeoung-Joon Kim (Chonnam National University Medical School, Korea)
Myungshin Kim (College of Medicine, The Catholic University of Korea, Korea)
Navigating cancer complexities via single-cell omics and AI Manoj Bhasin (Emory University, USA) Targeting the developmental heterogeneity of human acute myeloid leukemia Shanshan Pei (Zhejiang University, China) Mutational profile in Korean AML patients Jae-Sook Ahn (Chonnam National University Medical School, Korea)

[SS06] Scientific Session 06

Insights into lymphoma pathobiology

Room 1 (Vista Hall 1)

March 28 (Thu), 16:35-17:50
Gyeong-Sin Park (College of Medicine, The Catholic University of Korea, Korea)
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea)
Germinal center in the genesis of lymphomas Laura Pasqualucci (Columbia University, USA) Genomics of follicular lymphoma: Clinical implications? Robert Kridel (University Health Network, Canada) Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phe - notype: A multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression Jin Ho Paik (Seoul National University College of Medicine, Korea)

[SS07] Scientific Session 07

Profound understanding of diagnosis and therapy in MDS

Room 2 (Vista Hall 2)

March 28 (Thu), 16:35-17:50
Yoo Jin Kim (College of Medicine, The Catholic University of Korea, Korea)
Jun Ho Jang (Sungkyunkwan University School of Medicine, Korea)
Molecular alterations and clinical implications in MDS Yasushi Miyazaki (Nagasaki University, Japan) Recent advances and future therapeutic strategies in MDS Guillermo Garcia-Manero (The University of Texas MD Anderson Cancer Center, USA) Current diagnostic challenges in MDS In-Suk Kim (Pusan National University School of Medicine, Korea)

[SS08] Scientific Session 08

Leukemogenesis in children and adults

Room 3 (Grand Hall 1)

March 28 (Thu), 16:35-17:50
Kyung Ha Ryu (Ewha Womans University College of Medicine, Korea)
Hoon Kook (Chonnam National University Medical School, Korea)
RUNX1-FPDMM natural history study at NIH Pu Paul Liu (National Institutes of Health, USA) Clinical impact of DDX41 mutations in myeloid neoplasms Talha Badar (Mayo Clinic, USA) Discovery of new regulators in hematopoietic stem cells and malignancies Dongjun Lee (Pusan National University School of Medicine, Korea)

[ES02] Education Session 02

Basics for trainees

Room 4 (Art Hall)

March 28 (Thu), 16:35-17:50
Inho Kim (Seoul National University College of Medicine, Korea)
Jaewoo Song (Yonsei University College of Medicine, Korea)
Overview of lymphoma classification Tae-Jung Kim (College of Medicine, The Catholic University of Korea, Korea) What's new in AML classification Hee Sue Park (Chungbuk National University College of Medicine, Korea) Recent update of MDS classification Miyoung Kim (University of Ulsan College of Medicine, Korea)

Scientific Program

Sponsored by